HUH-1 Cells
General information
| Description | The HuH-1 cell line is derived from a human hepatocellular carcinoma (HCC) and is used extensively in liver cancer research. This cell line has shown the ability to produce and secrete various liver-specific proteins, including those typically found in human plasma. Notably, HuH-1 cells, like other human hepatoma cell lines, can express and release hepatitis B surface antigen (HBsAg) in culture, providing a model for studying hepatitis B virus-related HCC mechanisms. The ability to produce HBsAg in culture suggests that HuH-1 cells retain differentiated functions similar to those of liver cells in vivo. HuH-1 cells are also instrumental in the investigation of regulatory mechanisms in liver cancer, particularly those involving microRNAs and their targets. For example, studies have demonstrated that miR-182 upregulation can enhance the metastatic potential of HCC cells, including HuH-1, by downregulating metastasis suppressor 1 (MTSS1). This downregulation promotes invasive behavior and highlights the role of specific microRNAs in modulating gene expression and influencing cancer cell behavior. Such insights are valuable for understanding the progression of HCC and developing targeted therapeutic strategies. The HuH-1 cell line's utility extends to research on the tumor microenvironment and its interactions with viral elements, making it a suitable model for exploring the intricate relationships between oncogenes, suppressor genes, and viral proteins. This cell line aids in elucidating the multifaceted pathways of hepatocarcinogenesis and the development of anti-cancer therapies tailored to liver cancer's molecular underpinnings. |
|---|---|
| Organism | Human |
| Tissue | Liver |
| Disease | Adult hepatocellular carcinoma |
| Synonyms | huH-1, HuH-1, huH 1, HuH1, HUh1, HUH1, huH1 |
Characteristics
| Age | 53 years |
|---|---|
| Gender | Male |
| Ethnicity | Japanese |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | HUH-1 (Cytion catalog number 305553) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_2956 |
Biomolecular Data
| Viruses | Transformant: Hepatitis B virus (HBV). Cells are producing HBs-antigen continuously in culture medium. |
|---|---|
| Mutational profile | Mutation: AXIN1, p.Asn302Profs*111 (c.904_907delAACC); Mutation: TP53, p.Arg110Leu (c.329G>T), homozygous |
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with TrypLE Express, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 2-4*10^4/cm² |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|